Theravance Biopharma Inc (TBPH)
Change in Working Capital
$242.87M
TTM · Period ending: · USD
TBPH Change in Working Capital
Latest reported$242.87Mperiod ending
Latest reported$242.87Mperiod ending
TBPH TTM Change in Working Capital ($10.18M → $242.87M)
TTM change in working capital
High-resolution chart · PNG
TBPH change in working capital history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Change in Working Capital (USD) |
|---|---|
| 242,874,000 | |
| 478,416,000 | |
| 454,523,000 | |
| 206,740,000 | |
| 223,278,000 | |
| 68,174,000 | |
| 20,355,000 | |
| 3,054,000 | |
| 2,051,000 | |
| -6,511,000 | |
| -8,340,000 | |
| 54,630,000 | |
| 40,749,000 | |
| 48,590,000 | |
| 42,350,000 | |
| -24,722,000 | |
| -17,204,000 | |
| -32,261,000 | |
| -41,418,000 | |
| -48,231,000 | |
| -57,069,000 | |
| -45,133,000 | |
| -39,462,000 | |
| -23,669,000 | |
| -11,703,000 | |
| -23,229,000 | |
| -32,085,000 | |
| -41,983,000 | |
| -38,094,000 | |
| -57,768,000 | |
| 59,429,000 | |
| 91,662,000 | |
| 77,560,000 | |
| 119,447,000 | |
| 22,431,000 | |
| 26,292,000 | |
| 51,928,000 | |
| 47,014,000 | |
| 46,928,000 | |
| 15,907,000 | |
| 15,392,000 | |
| -3,802,000 | |
| -37,783,000 | |
| -30,850,000 | |
| -33,092,000 | |
| -19,195,000 | |
| 12,770,000 | |
| 12,237,000 | |
| 6,123,000 | |
| 14,498,000 | |
| 10,176,000 | |
| 5,939,000 | |
| 3,701,000 |